期刊
CELL
卷 128, 期 2, 页码 369-381出版社
CELL PRESS
DOI: 10.1016/j.cell.2006.12.033
关键词
-
资金
- NCI NIH HHS [CA69381, P01 CA069381] Funding Source: Medline
- NIAID NIH HHS [AI61549, R37AI33068, R21 AI061549] Funding Source: Medline
- NIGMS NIH HHS [GM071573, GM071862, P01 GM071862, R01 GM071573] Funding Source: Medline
Inflammatory NF-kappa B/RelA activation is mediated by the three canonical inhibitors, I kappa B alpha, -beta, and -epsilon. We report here the characterization of a fourth inhibitor, nf kappa b2/p100, that forms two distinct inhibitory complexes with RelA, one of which mediates developmental NF-kappa B activation. Our genetic evidence confirms that p100 is required and sufficient as a fourth I kappa B protein for noncanonical NF-kappa B signaling downstream of NIK and IKK1. We develop a mathematical model of the four-I kappa B-containing NF-kappa B signaling module to account for NF-kappa B/BelA:p50 activation in response to inflammatory and developmental stimuli and find signaling crosstalk between them that determines gene-expression programs. Further combined computational and experimental studies reveal that mutant cells with altered balances between canonical and noncanonical I kappa B proteins may exhibit inappropriate inflammatory gene expression in response to developmental signals. Our results have important implications for physiological and pathological scenarios in which inflammatory and developmental signals converge.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据